MIT and the company ’s microchip company recently announced that their remote-controlled drug delivery microchips, which they started researching 15 years ago, have been successful in human experiments for the first time. They implanted microchips into osteoporosis patients through a simple operation, and after a year of examination, they found that the effect was the same as that of injection. The success of this experiment is expected to lead a new era of telemedicine. Related papers were published on the website of "Science and Translational Medicine" on February 16.
This chip is a programmable, wireless remote control microchip, which can be programmed with a dosage schedule in advance, or remotely control the drug release through a special radio communication frequency called "Medical Implant Communication Device (MICS)". After the chip is implanted in the patient's body, it can manage the daily dosage according to the medication regulations. "With this kind of chip, you can really take the medicine according to the dose." Robert Lange, a professor at the David Koch College of Massachusetts Institute of Technology, said. The school's Michael Shima said: "Many drugs must strictly follow the medication regulations. If patients have to inject themselves, the situation is very troublesome. This technology completely avoids these troubles and can fully implement various drug regulations in the future. , Some chronic patients can benefit more from it. "
In January 2011, they conducted human clinical trials in Denmark. The subjects were 7 women aged 65 to 70 years. The operation process is only 30 minutes, and the chip can be stored in the patient for 4 months. The chip used contains 20 doses of teriparatide for the treatment of osteoporosis, which are sealed in needle-sized "warehouses". The lid of the warehouse is a thin layer of platinum-titanium alloy, which melts when a small current is applied To release the medicine inside. One year later, when the researchers examined the bone formation of the subjects, they found that the efficacy was the same as or better than those who received daily injection treatment.
The chip's current remote control distance is only a few inches, and there is room for further expansion. Robert Farah, lead author of the paper and director and CEO of Microchip, said that the chip can be used not only for osteoporosis, but also for many other diseases, including cancer and polyploid sclerosis. Greatly change the treatment.
Toner Cartridge For Brother,New Brother Compatible Toner,Tn2225 Black Toner Cartridge,Brand Brother Compatible Toner
jiangmen jinheng office equipment Co. Ltd. , https://www.jm-jinheng.com